"Someone" was just paid off. Remdesivir doesn't even work. Yet, the U.S. Department of Health and Human Services has recently “bought” all of Gilead Science’s Remdesivir for $1.6 billion. “500,000 doses at $3,200 per patient or giving them 3200% profit.
Amazing how payoffs are provided, no?
"Someone" was just paid off. Remdesivir doesn't even work. Yet, the U.S. Department of Health and Human Services has recently “bought” all of Gilead Science’s Remdesivir for $1.6 billion. “500,000 doses at $3,200 per patient or giving them 3200% profit.
Amazing how payoffs are provided, no?
(post is archived)